The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preclinical profile of GM102, a first-in-class antibody targeting AMHRII in ovarian cancers.
 
Jean-Marc Barret
Employment - GAMAMABS PHARMA
Honoraria - GAMAMABS PHARMA
Research Funding - Pierre Fabre (I)
Patents, Royalties, Other Intellectual Property - GAMAMABS PHARMA
Travel, Accommodations, Expenses - GAMAMABS PHARMA
 
Andre Pelegrin
No Relationships to Disclose
 
Didier Decaudin
No Relationships to Disclose
 
Christophe de Romeuf
No Relationships to Disclose
 
Marie-Eve Duclos
No Relationships to Disclose
 
Anne Bousseau
Employment - Sanofi
Leadership - Sanofi
Consulting or Advisory Role - Sanofi
Expert Testimony - Sanofi
Travel, Accommodations, Expenses - GAMAMABS PHARMA
 
Catherine Combot-Plétan
Employment - Roche (I)
Leadership - Roche (I)
Honoraria - Roche (I)
 
Jean-François Prost
Employment - Novartis (I)
Consulting or Advisory Role - SERVIER
Research Funding - GAMAMABS PHARMA
Patents, Royalties, Other Intellectual Property - GAMAMABS PHARMA